Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 14.3% decrease from the number of companies inspected in the previous month, when seven companies received seven inspections.
Most of the companies inspected at the time were involved in the Drugs sector. The second most common type of company inspected period worked in the Food and Cosmetics sector.
There were three companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct the organization's management operations. Additionally, one company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Contract Coating, Inc. | Drugs | 12/06/2024 | No Action Indicated (NAI) |
| Cosmetic Essence, Inc. | Drugs | 12/06/2024 | Voluntary Action Indicated (VAI) |
| Dairy Delight, LLC | Food and Cosmetics | 12/12/2024 | No Action Indicated (NAI) |
| Dora's Naturals, Inc. | Food and Cosmetics | 12/03/2024 | No Action Indicated (NAI) |
| Jamol Laboratories, Inc. | Drugs | 12/12/2024 | Official Action Indicated (OAI) |
| Specialty Vision, LLC | Devices | 12/19/2024 | Voluntary Action Indicated (VAI) |
Alerts Sign-up